Emzahh Tablet
Product Images NDC 59651-136

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Emzahh (NDC 59651-136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Norethindrone Fig1)

Figure 1 (Norethindrone Fig1)
An instructional diagram showing how to apply a day label to a weekly medication blister pack. A hand is peeling a label marked with days of the week to align it above the corresponding blister compartments. The blister pack contains circular pill spaces arranged in rows with arrows indicating pill-taking sequence.*
FDA Label Image

Package Label-principal Display Panel (0.35 mg Pouch Label)

Package Label-principal Display Panel (0.35 mg Pouch Label)
Emzahh (Norethindrone Tablets, USP) 0.35 mg oral tablet label showing a 28-day supply in a pouch containing 28 tablets. The label includes storage instructions, warnings, and is distributed by Aurobindo Pharma USA, Inc. It displays the NDC 59651-136-87 and highlights that each light yellow tablet contains 0.35 mg norethindrone.*
FDA Label Image

Package Label-principal Display Panel (0.35 mg Pouch Carton Label)

Package Label-principal Display Panel (0.35 mg Pouch Carton Label)
Emzahh Norethindrone Tablets, USP 0.35 mg oral tablets packaging label by Aurobindo Pharma Limited. The carton contains 6 pouches, each with 28 light yellow tablets. The label includes dosage storage instructions and warns that it does not protect against HIV/AIDS or other sexually transmitted diseases. Distributed by Aurobindo Pharma USA, made in India.*
FDA Label Image

Package Label-principal Display Panel (0.35 mg Blister Carton Label)

Package Label-principal Display Panel (0.35 mg Blister Carton Label)
Packaging label for Emzahh (Norethindrone Tablets, USP) 0.35 mg oral tablets by Aurobindo Pharma Limited. The carton contains 1 blister pack with 28 tablets. Label includes usage warnings, storage instructions, distributor information, and product identification including NDC 59651-136-28.*
FDA Label Image

Chemical Structure (Norethindrone Str)

Chemical Structure (Norethindrone Str)
Chemical structure of norethindrone, a steroidal compound with specific functional groups including hydroxyl and alkyne.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.